المؤلفون: Kanwal Pratap Singh Raghav, Li Liang, Robert A. Wolff, J. Morris, Bryan K. Kee, Imad Shureiqi, Van K. Morris, Thibault Mazard, Lianchun Xiao, Funda Meric-Bernstam, Gordon B. Mills, James L. Abbruzzese, Cathy Eng, Kenna Rael Shaw, Eduardo Vilar, Scott Kopetz, Michael J. Overman, Arvind Dasari, Rachna T. Shroff, David R. Fogelman, Dipen M. Maru, Stanley R. Hamilton

المساهمون: Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)

المصدر: Annals of Oncology
Annals of Oncology, Elsevier, 2016, 27 (6), pp.1068-1074. ⟨10.1093/annonc/mdw073⟩

مصطلحات موضوعية: 0301 basic medicine, MESH: Neoplasm Proteins, Male, Multivariate analysis, Colorectal cancer, Eligibility Determination, 0302 clinical medicine, MESH: Aged, 80 and over, MESH: DNA Methylation, MESH: CpG Islands, targeted, MESH: Aged, Aged, 80 and over, MESH: Middle Aged, Hematology, MESH: Neoplasm Staging, Middle Aged, 3. Good health, Neoplasm Proteins, Oncology, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, MESH: Biomarkers, Tumor, Fluorouracil, Colorectal Neoplasms, Adult, medicine.medical_specialty, colorectal cancer, [SDV.CAN]Life Sciences [q-bio]/Cancer, 03 medical and health sciences, MESH: Eligibility Determination, Internal medicine, medicine, Biomarkers, Tumor, Humans, MESH: Patient Selection, molecular, Aged, Neoplasm Staging, Gynecology, MESH: Humans, Performance status, business.industry, screening, Patient Selection, Cancer, MESH: Adult, Odds ratio, Original Articles, DNA Methylation, medicine.disease, prescreening, MESH: Male, Clinical trial, 030104 developmental biology, CpG Islands, business, MESH: Female, MESH: Fluorouracil, MESH: Colorectal Neoplasms, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e904e3ae1567c32e922a118ca1ebc2b1
https://europepmc.org/articles/PMC6276928/

المؤلفون: Philippe, Nicot, Irène, Frachon, Catherine, Hill

المساهمون: Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Département de Médecine Interne et Pneumologie [Brest] (DMIP - Brest), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Institut Gustave Roussy (IGR)

المصدر: La Presse medicale
La Presse medicale, Paris, Masson et Cie, 2013, 42 (4 Pt 1), pp.411-8. ⟨10.1016/j.lpm.2013.02.310⟩

مصطلحات موضوعية: MESH: Mitral Valve Insufficiency, MESH: Expert Testimony, Drug Industry, MESH: Probability, [SDV]Life Sciences [q-bio], Aortic Valve Insufficiency, Eligibility Determination, MESH: Causality, MESH: Fenfluramine, Diagnosis, Differential, MESH: Cross-Sectional Studies, MESH: Eligibility Determination, Risk Factors, MESH: Appetite Depressants, MESH: Risk Factors, MESH: Diagnosis, Differential, Appetite Depressants, Fenfluramine, Drugs, Generic, Humans, Expert Testimony, MESH: Drugs, Generic, Probability, MESH: Humans, MESH: Compensation and Redress, Mitral Valve Insufficiency, MESH: Aortic Valve Insufficiency, Causality, MESH: France, Cross-Sectional Studies, MESH: Drug Industry, Compensation and Redress, France

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ebc8a6a7a6ef4ef74b6a4ab69d4be3dd
https://hal.univ-brest.fr/hal-00935392